Indefinite Delivery Contract HHSN271201600005I

This $49.9 million Indefinite Delivery Contract was awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to PPD Development LP, a global contract research organization (CRO) subsidiary of Thermo Fisher Scientific. The contract is for research and development related to clinical studies under NIDA's Blueprint MedTech program, which focuses on medical technology development for nervous system disorders. Under this IDC, PPD will provide a range of services including developing...

This federal contract IDV, awarded by the Defense Health Agency (DHA), provides a $2,500.00 delivery order to PPD Development LP, a global contract research organization (CRO), for military medical research and development services. The IDV is part of a larger $545 million contract that PPD Development LP holds with the National Institute of Allergy and Infectious Diseases (NIAID) for comprehensive and rapid response capabilities in research programs. PPD Development LP, a subsidiary of Thermo...

This indefinite delivery contract awarded by the National Institute on Drug Abuse (NIDA), a civilian federal agency, to PPD Development LP, a global contract research organization (CRO) subsidiary of Thermo Fisher Scientific, provides regulatory consulting assistance and research and development support for medical device development projects under the Blueprint MedTech (BPMT) program. The contract has a ceiling value of $24 million over a 5-year ordering period from September 2022 to...

This is a multiple award Indefinite Delivery Contract (IDC) awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to provide comprehensive early phase clinical trial services. The $346.6 million contract, titled "Early Phase Clinical Trial Units (EPCTU)", facilitates Phase 0 through Phase II trials of investigational products against infectious diseases over a 10-year ordering period from...

This Indefinite Delivery Contract (IDC) was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) to PPD Development LP, a global contract research organization (CRO). The contract has a total potential value of $3,912,150 and provides comprehensive, integrated drug development, laboratory, and lifecycle management services to support NCATS' bioanalytical method development programs. This...

This Indefinite Delivery Contract is a parent IDIQ vehicle awarded by the National Institutes of Health's National Institute of Neurological Disorders and Stroke to Southern Research Institute, a non-profit research organization. The Pharmacology and Toxicology for Therapeutics Program (PTTP) IDIQ has a total potential value of $174,470,000 and a period of performance through September 12, 2026. Under this IDIQ, Southern Research has been awarded multiple task orders to provide drug discovery,...

The National Institute of Neurological Disorders and Stroke (NINDS), a civilian federal agency, has awarded Psychogenics Inc., a for-profit preclinical contract research organization, a $69.1 million cost-plus-fixed-fee delivery order contract to provide screening of investigational agents through the NINDS Preclinical Screening Platform for Pain (PSPP) program. This delivery order is part of a larger $49.9 million single-award indefinite delivery contract between NINDS and Psychogenics to...

This single-award IDV was issued by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases to provide centralized clinical laboratory services in support of clinical research trials. With a potential value of $5,000,000 and a period of performance through May 2026, the awardee PPD Development LP will deliver services including specimen handling, testing, data management, and clinical trial support. The originating...

The National Institute of Neurological Disorders and Stroke (NINDS), a civilian agency within the Department of Health and Human Services, awarded an Indefinite Delivery Contract (IDC) with a ceiling value of $37,393,571 to Curia Global Inc., doing business as Amri, a leading global contract development and manufacturing organization (CDMO). The IDC, titled the "Drug Manufacturing and Formulation Program (DMFP)," provides a broad range of pharmaceutical research and development...

The National Institutes of Health National Center for Advancing Translational Sciences awarded multiple indefinite delivery contracts to support its drug development programs. The IDVs have a potential value of $19.4 million and a period of performance through June 2027. CCS Associates, Inc. received task orders against its IDV to provide regulatory support services. A $115,581 order involves preparing a Pre-Investigational New Drug Application for clinical development of mitragynine. A $242,355...